DelveInsight’s Hepatitis D Virus Infection Market Insights Report offers a detailed analysis of the disease, its causes, symptoms, diagnostics modalities, and treatment options.
The Hepatitis D Virus Infection market report also offers comprehensive insights into Hepatitis D Virus Infection market size, epidemiology, emerging therapies, market drivers, market barriers, ongoing clinical trials, key collaboration in the space, and key pharmaceutical companies actively pushing the growth of Hepatitis D Virus Infection market size forward.
%20Infection%20Market.jpg?1631593596607 "Hepatitis D Virus (HDV) Infection Market: Market Outlook, Epidemiology Analysis, Treatment Landscape, Pipeline Products, and Key Companies Working in the Space 4")
Some of the key highlights from the Hepatitis D Virus Infection Market Insights:
- According to the World Health Organization (WHO) estimates, the Hepatitis D virus (HDV) globally affects nearly 5% of people who have a chronic infection with hepatitis B virus (HBV).
- In the 7MM, the total diagnosed HDV prevalent cases were found to be around 221,585 in 2018. These cases are expected to grow with a significant CAGR in the study period 2018–2030.
- In EU-5 countries the highest number of diagnosed prevalent cases of HDV was in Germany followed by Italy, Spain, the United Kingdom, and France.
- Major pharmaceutical players such as MYR Pharmaceuticals/Hepatera, Eiger Biopharmaceuticals, Janssen Pharmaceuticals, and others are involved in developing therapies for the treatment and management of Hepatitis D Virus Infection. These therapies are currently under different stages of development.
- Key pipeline therapies in the Hepatitis D Virus Infection market include Hepcludex/Bulevirtide, Lonafarnib, JNJ-73763989, among others.
Learn more by requesting for sample @ Hepatitis D Virus Infection Market Landscape
Hepatitis D Virus Infection: Overview
Hepatitis D Virus Infection is a viral infection that causes liver inflammation, sometimes leading to serious liver damage. It is caused by the hepatitis D virus (HDV) and is considered to be the most severe form of viral hepatitis in humans due to more rapid progression toward liver-related death and hepatocellular carcinoma.
Hepatitis D Virus Infection requires hepatitis B virus (HBV) for its replication. HDV infection occurs as co-infection or as super-infection with HBV.
HDV affects nearly 5% of people who have a chronic infection with HBV and that HDV co-infection could explain about 1 in 5 cases of liver disease and liver cancer in people with HBV infection.
For more insights into Disease, causes, and treatment, reach out to Hepatitis D Virus Infection Treatment Landscape
Hepatitis D Virus Infection Epidemiology Segmentation
The Hepatitis D Virus Infection Market report proffers epidemiological analysis for the study period 2017-30 in the 7MM segmented into:
- Hepatitis D Virus Infection Prevalence
- Age-Specific Hepatitis D Virus Infection Prevalence
- Gender-Specific Hepatitis D Virus Infection Prevalence
- Diagnosed and Treatable Cases of Hepatitis D Virus Infection
Visit for more @ Hepatitis D Virus Infection Epidemiological Insights
Hepatitis D Virus Infection Market
The Hepatitis D Virus (HDV) market dynamics is anticipated to change in the coming years. Key players, such as MYR Pharmaceuticals, Eiger Biopharmaceuticals, and Janssen Pharmaceuticals, etc. are involved in developing drugs for Hepatitis D Virus (HDV).
Hepatitis D Virus Infection Pipeline Therapies and Key Companies
- Hepcludex/Bulevirtide: MYR Pharmaceuticals/Hepatera
- Lonafarnib: Eiger Biopharmaceuticals
- JNJ-73763989: Janssen Pharmaceuticals
For more information, visit Hepatitis D Virus Infection Market Analysis, Patient Pool and Emerging Therapies
Hepatitis D Virus Infection Market Drivers
- Rising prevalent population
- Technological advancements
- Emerging therapies
- Extensive R&D
Scope of the Report
- 11 Years Forecast
- 7MM Coverage
- Descriptive overview of Hepatitis D Virus Infection, covering causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
- Comprehensive insight into Hepatitis D Virus Infection epidemiology and treatment in the 7MM
- Current and emerging therapies for Hepatitis D Virus Infection
- Hepatitis D Virus Infection market drivers and barriers
Key Questions Answered in the Report
- What was the Hepatitis D Virus Infection market share (%) distribution in 2017 and how it would look like in 2030?
- What would be the Hepatitis D Virus Infection total market size as well as market size by therapies across the 7MM during the forecast period (2017-2030)?
- What are the key findings pertaining to the market across 7MM and which country will have the largest Hepatitis D Virus Infection market size during the forecast period (2017-2030)?
- At what CAGR, the Hepatitis D Virus Infection market is expected to grow in 7MM during the forecast period (2017-2030)?
Get in touch with our Business executive @ Hepatitis D Virus Infection Market Landscape Analysis
Table of Contents
| 1. | Key Insights |
| 2. | Report Introduction |
| 3. | Competitive Intelligence Analysis for Hepatitis D Virus Infection |
| 4. | Hepatitis D Virus Infection Market Overview at a Glance |
| 5. | Executive Summary of Hepatitis D Virus Infection |
| 6. | Hepatitis D Virus Infection Epidemiology and Market Methodology |
| 7. | Hepatitis D Virus Infection Epidemiology and Patient Population |
| 8. | Hepatitis D Virus Infection Patient Journey |
| 9. | Treatment Algorithm, Current Treatment, and Medical Practices |
| 10. | Key Endpoints in Hepatitis D Virus Infection Clinical Trials |
| 11. | Hepatitis D Virus Infection Marketed Therapies |
| 12. | Hepatitis D Virus Infection Emerging Therapies |
| 13. | Hepatitis D Virus Infection: 7 Major Market Analysis |
| 14. | Attribute analysis |
| 15. | Access and Reimbursement Overview of Hepatitis D Virus Infection |
| 16. | KOL Reviews |
| 17. | Case Reports |
| 18. | Hepatitis D Virus Infection Market Drivers |
| 19. | Hepatitis D Virus Infection Market Barriers |
| 20. | SWOT Analysis |
| 21. | Disclaimer |
| 22. | DelveInsight Capabilities |
| 23. | About DelveInsight |
Learn more about the report offerings @ Hepatitis D Virus Infection Market Outlook
Related Reports:
Hepatitis D Virus Infection Epidemiology
DelveInsight’s ‘Hepatitis D Virus Infection – Epidemiology Forecast to 2030’ report.
Hepatitis D Virus Infection Pipeline
DelveInsight’s ‘Hepatitis D Pipeline Insight’ report.
Latest Reports:
Intrahepatic Cholangiocarcinoma (ICCA) Market
DelveInsight’s ‘Intrahepatic Cholangiocarcinoma (ICCA) – Market Insights, Epidemiology, and Market Forecast–2030’ report.
COVID 19 Therapeutic Pipeline, Vaccines, and Diagnostics Competitive Landscape, 2020
DelveInsight’s ‘COVID 19 (Novel Coronavirus 19) Therapeutic Pipeline, Vaccines, and Diagnostics Competitive Landscape, 2020’ report.
DelveInsight’s “Cervical Dysplasia – Market Insights, Epidemiology, and Market Forecast-2030” report.
DelveInsight’s “Agoraphobia – Market Insights, Epidemiology, and Market Forecast-2030” report.
DelveInsight’s “Hydrocephalus – Market Insights, Epidemiology, and Market Forecast-2030” report.
DelveInsight’s ‘Sarcopenia–Market Insights, Epidemiology, and Market Forecast-2030’ report.
Diabetic Kidney Disease Market
DelveInsight’s “Diabetic Kidney Disease (DKD) – Market Insights, Epidemiology, and Market Forecast-2030” report.
DelveInsight’s ‘Acromegaly-Market Insights, Epidemiology, and Market Forecast–2030’ report.
Acute Respiratory Distress Syndrome (ARDS) Market
DelveInsight’s ‘Acute Respiratory Distress Syndrome (ARDS) – Market Insights, Epidemiology and Market Forecast – 2030’ report.
Acute Kidney Injury (AKI) Market
DelveInsight’s ‘Acute Kidney Injury (AKI) – Market Insights, Epidemiology and Market Forecast– 2030’ report.
DelveInsight’s “Renal Anemia – Market Insights, Epidemiology, and Market Forecast-2030” report.
Healthcare Blogs:
Search for the Cure Continues in the Chronic Hepatitis B Treatment Market
Get in touch with our Business Executive for Competitive Intelligence Services
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
Contact Information:
Kritika Rehani info@delveinsight.com +1(919)321-6187
Tags:
IPS, Reportedtimes, PR-Wirein, Menafn, iCN Internal Distribution, Extended Distribution, Research Newswire, English
Contact Information:
Kritika Rehani
info@delveinsight.com
+1(919)321-6187
